Panganiban, Jackelyn P.
HRN: 21-19-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2024
CO-AMOXICLAV 625MG (TAB)
03/09/2024
03/16/2024
PO
625MG
BID
2nd Degree Perineal Laceration
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes